Article Commentary: Dealing with Diversity in Computational Cancer Modeling
Open Access
- 1 January 2013
- journal article
- editorial
- Published by SAGE Publications in Cancer Informatics
- Vol. 12, CIN.S11583-124
Abstract
This paper discusses the need for interconnecting computational cancer models from different sources and scales within clinically relevant scenarios to increase the accuracy of the models and speed up their clinical adaptation, validation, and eventual translation. We briefly review current interoperability efforts drawing upon our experiences with the development of in silico models for predictive oncology within a number of European Commission Virtual Physiological Human initiative projects on cancer. A clinically relevant scenario, addressing brain tumor modeling that illustrates the need for coupling models from different sources and levels of complexity, is described. General approaches to enabling interoperability using XML-based markup languages for biological modeling are reviewed, concluding with a discussion on efforts towards developing cancer-specific XML markup to couple multiple component models for predictive in silico oncology.Keywords
This publication has 58 references indexed in Scilit:
- Personalizing medicine: a systems biology perspectiveMolecular Systems Biology, 2009
- Evolution of cell motility in an individual-based model of tumour growthJournal of Theoretical Biology, 2009
- In silico cancer modeling: is it ready for prime time?Nature Clinical Practice Oncology, 2008
- Cross-scale sensitivity analysis of a non-small cell lung cancer model: Linking molecular signaling properties to cellular behaviorBioSystems, 2008
- A hybrid cellular automaton model of clonal evolution in cancer: The emergence of the glycolytic phenotypeJournal of Theoretical Biology, 2008
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- An evolutionary hybrid cellular automaton model of solid tumour growthJournal of Theoretical Biology, 2007
- Predictive oncology: A review of multidisciplinary, multiscale in silico modeling linking phenotype, morphology and growthNeuroImage, 2007
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- A four-dimensional simulation model of tumour response to radiotherapy in vivo: parametric validation considering radiosensitivity, genetic profile and fractionationJournal of Theoretical Biology, 2004